![Biovaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines - Biovaxys Biovaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines - Biovaxys](https://biovaxys.com/wp-content/uploads/2021/02/biovaxys-procare-health-eng.jpg)
Biovaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines - Biovaxys
![BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps - Biovaxys BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps - Biovaxys](https://biovaxys.com/wp-content/uploads/2022/10/Procare-Health.jpg)
BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps - Biovaxys
!['Papilocare', eficaz en la normalización de las lesiones causadas por el VPH - El médico interactivo 'Papilocare', eficaz en la normalización de las lesiones causadas por el VPH - El médico interactivo](https://elmedicointeractivo.com/wp-content/uploads/2019/11/procare.jpg)
'Papilocare', eficaz en la normalización de las lesiones causadas por el VPH - El médico interactivo
![BioVaxys (CSE:BIOV) signs binding term sheet for distribution of Papilocare in the U.S. | The Market Herald Canada BioVaxys (CSE:BIOV) signs binding term sheet for distribution of Papilocare in the U.S. | The Market Herald Canada](https://cdn.jwplayer.com/thumbs/zsxE84Bs-1280.jpg)